Search filters

List of works by Crystal Watson

A National Plan to Enable Comprehensive COVID-19 Case Finding and Contact Tracing in the US ⬇️

Plan proposal to establish contact tracing forces to address the COVID-19 pandemic in the United States

A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy

scientific article published on 5 December 2013

A cross-sectional analysis of cardiovascular disease in the hemophilia population

scientific article published on 01 June 2018

Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States ⬇️

scientific article published on December 8, 2011

Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey

scientific article

Clade X: A Pandemic Exercise

scientific article published on 01 September 2019

Cost per Treated Patient for Etanercept, Adalimumab, and Infliximab Across Adult Indications: a Claims Analysis ⬇️

scientific article published on 09 March 2012

Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden

scientific article

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population

scientific article

Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care population ⬇️

scientific article published on 03 April 2013

Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan

scientific article published on 16 August 2012

Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis

scientific article published on January 2010

Factors Associated With the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study ⬇️

scientific article published on January 28, 2012

Federal Funding for Health Security in FY2018.

scientific article published on 27 June 2017

Federal Funding for Health Security in FY2019

article

Frequency of Risk-Related News Media Messages in 2016 Coverage of Zika Virus

scientific article published on 3 January 2018

Global Catastrophic Biological Risks: Toward a Working Definition

scientific article published on 26 July 2017

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

scientific article published on February 2017

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.

scientific article published on 19 December 2013

Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States

scientific article

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

scientific article

Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon

scientific article published on 02 November 2018

Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients

scientific article published in June 2015

Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

scientific article published on 5 June 2012

Risk-Based Decision Making During Public Health Emergencies Involving Environmental Contamination

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

scientific article published on 23 February 2016

The Joint External Evaluation of Taiwan: The External Evaluators' Perspective

scientific article published in March 2017

Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings ⬇️

scientific article published on 08 August 2012

Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample

scientific article published on 07 March 2014

Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States

scientific article published in October 2013

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

scientific article published on 21 May 2013

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

scientific article published on 20 July 2018

Vector control in Zika-affected communities: Local views on community engagement and public health ethics during outbreaks

scientific article published on 25 January 2020

Paulina is supported by:

About Paulina

Help